Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
848.92B
Market cap848.92B
Price-Earnings ratio
38.51
Price-Earnings ratio38.51
Dividend yield
0.70%
Dividend yield0.70%
Average volume
3.00M
Average volume3.00M
High today
$904.80
High today$904.80
Low today
$871.73
Low today$871.73
Open price
$900.42
Open price$900.42
Volume
4.46M
Volume4.46M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 848.92B, Eli Lilly(LLY) trades at $884.11. The stock has a price-to-earnings ratio of 38.51 and currently yields dividends of 70.5%.

During the trading session on 2026-04-25, Eli Lilly(LLY) shares reached a daily high of $904.80 and a low of $871.73. At a current price of $884.11, the stock is +1.4% higher than the low and still -2.3% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 4.46M, versus its average volume of 3M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

The Wall Street Journal 21h
Lilly Shares Slip on Weak Early Data From its Obesity Pill

Eli Lilly shares slid nearly 4% Friday after early data on prescription volume for its new weight loss pill signaled it’s off to a slow start. Lilly began sell...

Lilly Shares Slip on Weak Early Data From its Obesity Pill
Investor's Business Daily 1d
Battle Of The Weight-Loss Pills Continues With A Shocking Twist

Technology Battle Of The Weight-Loss Pills Continues With A Shocking Twist Licensing Eli Lilly (LLY) stock skidded early Friday as Novo Nordisk's (NVO) Wegovy p...

Battle Of The Weight-Loss Pills Continues With A Shocking Twist
Simply Wall St 1d
Amazon GLP-1 Push Tests Eli Lilly Valuation And Growth Expectations

Amazon has launched a GLP-1 obesity drug care program that integrates One Medical telehealth and its pharmacy services. The program is designed to streamline a...

Amazon GLP-1 Push Tests Eli Lilly Valuation And Growth Expectations

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

TipRanks 2d
Eli Lilly Expands Partnership with Hims & Hers

The stock of Hims & Hers Health (HIMS) was up as much as 7% on April 23 after the company announced that it has expanded its partnership with Eli Lilly (LLY)....

Barron's 2d
Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing.

Biotech and Pharma Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing. In this article LLY NVO SPX Eli Lilly is the mak...

Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing.
Simply Wall St 2d
Hims & Hers Health Is Up 19.4% After Expanding GLP-1 Access Via LillyDirect Integration

Earlier this week, Hims & Hers Health said clinicians on its platform can now prescribe Eli Lilly GLP-1 weight loss drugs, which will be filled through LillyDir...

Hims & Hers Health Is Up 19.4% After Expanding GLP-1 Access Via LillyDirect Integration
Sherwood News 2d
Hims rises after it says it now offers “full range” of FDA-approved GLP-1s

Hims & Hers rose in early trading after it announced that it now allows its providers to prescribe medications that are fulfilled by independent pharmacies, mea...

Hims rises after it says it now offers “full range” of FDA-approved GLP-1s
Investor's Business Daily 2d
Hims & Hers Jumps On Its New Eli Lilly-Tied Approach To Obesity

Obesity Drugs Covered In Medicare Change. Questions Remain For Lilly, Novo. 4/22/2026 CMS flipped its stance late Tuesday, saying it will cover the cost of obe...

Hims & Hers Jumps On Its New Eli Lilly-Tied Approach To Obesity
The Motley Fool 2d
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Investors looking to capitalize on the rapidly growing weight-loss market face a difficult choice. Eli Lilly (LLY +2.04%) is the leader in the field, but some w...

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
The Motley Fool 3d
Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.

At first glance, Eli Lilly's (LLY +1.97%) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assu...

Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.